Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Taiwan Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20053
20062
20075
20084
20094
20102
20113
20126
20136
20145
20158
20162
20174
20185
20195
20204
20219
20228
20235
20245
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Terminated18
Active, not recruiting16
Recruiting13
Unknown status5
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
AstraZeneca9
Eli Lilly and Company8
National Taiwan University Hospital7
Pfizer6
Hoffmann-La Roche5
Janssen Research & Development, LLC4
Bristol-Myers Squibb3
Daiichi Sankyo3
EMD Serono Research & Development Institute, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung106
Lung Neoplasms24
Neoplasms14
Neoplasm Metastasis9
Melanoma8
Adenocarcinoma of Lung7
Pancreatic Neoplasms6
Breast Neoplasms4
Carcinoma4
Ovarian Neoplasms4

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.